Characterizing patterns of drug-taking behavior with a multiple drug regimen in an AIDS clinical trial

AIDS

Volumn 12, Issue 17, 1998, Pages 2295-2303

  Kastrissios, Helen ^a,c   Suárez, José Ramón ^a,d   Katzenstein, David ^a   Girard, Pascal ^b,e   Sheiner, Lewis B ^b   Blaschke, Terrence F ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^d SANOFI   (France)

^e LOUIS PRADEL HOSPITAL   (France)

Author keywords

Adherence; Combination therapy; Compliance; Didanosine; Electronic monitoring; Nucleoside analogs; Zalcitabine; Zidovudine

Indexed keywords

DIDANOSINE; NUCLEOSIDE ANALOG; PLACEBO; ZALCITABINE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PATIENT COMPLIANCE; PATIENT MONITORING; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0032480985     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199817000-00011     Document Type: Article

References (23)

1. NIH Panel: Report of the NIH Panel to Define Principles of Therapy of HIV Infection. Ann Intern Med 1998, 128:1057-1078.
2. Cramer JA, Mattson RH, Prevey ML, Scheyer RD, Ouellette VL: How often is medication taken as prescribed? A novel assess ment technique. JAMA 1989, 261:3273-3277.
3. Eldred LJ, Wu AW, Chaisson RE, Moore RD: Adherence to antiretroviral and Pneumocystis prophylaxis in HIV disease. J Acquir Immune Defic Syndr Hum Retrovirol 1998, 18:117-125.
4. Kruse W, Eggert-Kruse W, Rampmaier J, Runnebaum B, Weber E: Dosage frequency and drug-compliance behaviour: a comparative study on compliance with a medication to be taken twice or four times daily. Eur J Clin Pharmacol 1991, 41:589-592.
5. Vander Stichele R: Measurement of patient compliance and the interpretation of randomized clinical trials. Eur J Clin Pharmacol 1991, 41:27-35.
6. Kastrissios H, Suarez JR, Hammer S, Katzenstein D, Blaschke TF: The extent of non-adherence in a large AIDS clinical trial using plasma dideoxynucleoside concentrations as a marker. AIDS 1998, 12:2305-2311.
7. Hammer SM, Katzenstein DA, Hughes MD, et al.: A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter. N Engl J Med 1996, 335:1081-1090.
8. Urquhart J: Ascertaining how much compliance is enough with outpatient antibiotic regimens. Postgrad Med J 1992, 68 (suppl 3):S49-S59.
9. Sommadossi JP: Nucleoside analogs: similarities and differences. Clin Infect Dis 1993, 16 (suppl 1):S7-S15.
10. Urquhart J: Role of patient compliance in clinical pharmacokinetics. A review of recent research. Clin Pharmacokinet 1994, 27:202-215.
11. Peck CC, Barr WH, Benet LZ, et al.: Opportunities for integration of pharmacokinetics, pharmacodynamics, and toxicokinetics in rational drug development. Clin Pharmacol Ther 1992, 51:465-473.
12. Urquhart J, de Klerk E: Contending paradigms for the interpretation of data on patient compliance with therapeutic drug regimens. Stat Med 1998, 17:251-267.
13. Eisen SA, Miller DK, Woodward RS, Spitznagel E, Przybeck TR: The effect of prescribed daily dose frequency on patient medication compliance. Arch Intern Med 1990, 150:1881-1884.
14. Urquhart J: Real-time compliance data to help define optimal drug regimens. Ann NY Acad Sci 1991, 618:522-532.
15. Rudd P, Ahmed S, Zachary V, Barton C, Bonduelle D: Improved compliance measures: applications in an ambulatory hypertensive drug trial. Clin Pharmacol Ther 1990, 48:676-685.
16. Waterhouse DM, Calzone KA, Mele C, Brenner DE: Adherence to oral tamoxifen: a comparison of patient self-report, pill counts, and microelectronic monitoring. J Clin Oncol 1993, 11:1189-1197.
17. Guerrero D, Rudd P, Bryant-Kosling C, Middleton BF: Antihypertensive medication-taking. Investigation of a simple regimen. Am J Hypertens 1993, 6:586-592.
18. Kastrissios H, Blaschke TF: Medication compliance as a feature in drug development. Annu Rev Pharmacol Toxicol 1997, 37:451-475.
19. Bond WS, Hussar DA: Detection methods and strategies for improving medication compliance. Am J Hosp Pharm 1991, 48:1978-1988.
20. Vanhove GF, Schapiro JM, Winters MM, Merigan TC, Blaschke TF: Patient compliance and drug failure in protease inhibitor monotherapy. JAMA 1996, 276:1955-1956.
21. Katzenstein DA, Lyons C, Molaghan JP, Ungvarski P, Wolfe GS, Williams A: HIV therapeutics: confronting adherence. J Assoc Nurses AIDS Care 1997, 8 (suppl):46-58.
22. Ickovics JR, Meisler A. Adherence in AIDS clinical trials: a framework for clinical research and clinical care. J Clin Epidemiol 1997, 50:385-391.
23. Girard P, Blaschke TF, Kastrissios H, Sheiner LB: A Markov mixed effect regression model for drug compliance. Stat Med 1998, 17:2313-2333.